This statistic shows (click here) the leading AIDS drugs worldwide based on revenue from 2009 to 2014. In 2009, GlaxoSmithKline's Combivir generated a revenue of 663 million U.S. dollars. However, this revenue decreased to under 200 million U.S. dollars in 2013.
The word is out, stop trying to kill Dr. Sam. You guys got no class. No class at all. Not even ethical content. But, given the fact life doesn't matter to Big Pharma it is more an issue of ego than professional standards. I consider obscene profit an ego issue. Just can't get enough.
30 November 2015
...That represents compounded (click here) annual growth of 10 per cent between 2005 and 2009. The US was the biggest market, booking $7.7bn in antiretroviral sales last year. France was the largest of the European markets, with sales of $1.1bn, while Japan was the smallest overall. In terms of patients, the number of people living with HIV across the seven major markets went from 1.4 million in 2001 to 1.8 million in 2009, with further increases expected in the coming decade. The US is forecast to hold on to first place, with Datamonitor expecting it to account for 60 per cent of sales across the seven markets in 2019. Japan is forecast to remain the smallest....
In case Big Pharma was confused as to how to manufacture the vaccines? It is called a compounding pharmacy.
The word is out, stop trying to kill Dr. Sam. You guys got no class. No class at all. Not even ethical content. But, given the fact life doesn't matter to Big Pharma it is more an issue of ego than professional standards. I consider obscene profit an ego issue. Just can't get enough.
30 November 2015
...That represents compounded (click here) annual growth of 10 per cent between 2005 and 2009. The US was the biggest market, booking $7.7bn in antiretroviral sales last year. France was the largest of the European markets, with sales of $1.1bn, while Japan was the smallest overall. In terms of patients, the number of people living with HIV across the seven major markets went from 1.4 million in 2001 to 1.8 million in 2009, with further increases expected in the coming decade. The US is forecast to hold on to first place, with Datamonitor expecting it to account for 60 per cent of sales across the seven markets in 2019. Japan is forecast to remain the smallest....
In case Big Pharma was confused as to how to manufacture the vaccines? It is called a compounding pharmacy.